217 related articles for article (PubMed ID: 36476434)
1. Therapies for Type 1 Diabetes: Is a Cure Possible?
Chuzho N; Mishra N; Tandon N; Kumar N
Curr Diabetes Rev; 2023; 19(7):e021222211565. PubMed ID: 36476434
[TBL] [Abstract][Full Text] [Related]
2. Do immunotherapy and beta cell replacement play a synergistic role in the treatment of type 1 diabetes?
Li DS; Warnock GL; Tu HJ; Ao Z; He Z; Lu H; Dai LJ
Life Sci; 2009 Oct; 85(15-16):549-56. PubMed ID: 19747492
[TBL] [Abstract][Full Text] [Related]
3. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.
Fändrich F; Ungefroren H
Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518
[TBL] [Abstract][Full Text] [Related]
4. Stem cell-based immunomodulation in type 1 diabetes: beyond the regenerative approach.
Longoni B; Mosca F
Curr Pharm Des; 2011; 17(29):3229-42. PubMed ID: 21864271
[TBL] [Abstract][Full Text] [Related]
5. Local Immunomodulatory Strategies to Prevent Allo-Rejection in Transplantation of Insulin-Producing Cells.
Wang X; Brown NK; Wang B; Shariati K; Wang K; Fuchs S; Melero-Martin JM; Ma M
Adv Sci (Weinh); 2021 Sep; 8(17):e2003708. PubMed ID: 34258870
[TBL] [Abstract][Full Text] [Related]
6. The state of the art of islet transplantation and cell therapy in type 1 diabetes.
Pellegrini S; Cantarelli E; Sordi V; Nano R; Piemonti L
Acta Diabetol; 2016 Oct; 53(5):683-91. PubMed ID: 26923700
[TBL] [Abstract][Full Text] [Related]
7. Engineering β Cell Replacement Therapies for Type 1 Diabetes: Biomaterial Advances and Considerations for Macroscale Constructs.
Quizon MJ; García AJ
Annu Rev Pathol; 2022 Jan; 17():485-513. PubMed ID: 34813353
[TBL] [Abstract][Full Text] [Related]
8. Recent trends and advances in type 1 diabetes therapeutics: A comprehensive review.
Singh A; Afshan N; Singh A; Singh SK; Yadav S; Kumar M; Sarma DK; Verma V
Eur J Cell Biol; 2023 Jun; 102(2):151329. PubMed ID: 37295265
[TBL] [Abstract][Full Text] [Related]
9. Animal models to study adult stem cell-derived, in vitro-generated islet implantation.
Peck AB; Yin L; Ramiya V
ILAR J; 2004; 45(3):259-67. PubMed ID: 15229373
[TBL] [Abstract][Full Text] [Related]
10. Challenges with Cell-based Therapies for Type 1 Diabetes Mellitus.
Siwakoti P; Rennie C; Huang Y; Li JJ; Tuch BE; McClements L; Xu X
Stem Cell Rev Rep; 2023 Apr; 19(3):601-624. PubMed ID: 36434300
[TBL] [Abstract][Full Text] [Related]
11. 3D Bioprinting and Translation of Beta Cell Replacement Therapies for Type 1 Diabetes.
Gurlin RE; Giraldo JA; Latres E
Tissue Eng Part B Rev; 2021 Jun; 27(3):238-252. PubMed ID: 32907514
[TBL] [Abstract][Full Text] [Related]
12. A Stem Cell Approach to Cure Type 1 Diabetes.
Helman A; Melton DA
Cold Spring Harb Perspect Biol; 2021 Jan; 13(1):. PubMed ID: 32122884
[TBL] [Abstract][Full Text] [Related]
13. Cell Therapy for Type 1 Diabetes: Current and Future Strategies.
Aghazadeh Y; Nostro MC
Curr Diab Rep; 2017 Jun; 17(6):37. PubMed ID: 28432571
[TBL] [Abstract][Full Text] [Related]
14. Islet Cell Therapy and Stem Cell Therapy for Type 1 Diabetes: There Will Always Be a Hope.
Hatipoglu BA; Blanchette J
Endocrinol Metab Clin North Am; 2023 Mar; 52(1):187-193. PubMed ID: 36754494
[TBL] [Abstract][Full Text] [Related]
15. In search of a surrogate: engineering human beta cell lines for therapy.
Newby BN; Terada N; Mathews CE
Trends Endocrinol Metab; 2014 Aug; 25(8):378-80. PubMed ID: 24958526
[TBL] [Abstract][Full Text] [Related]
16. From islet transplantation to beta-cell regeneration: an update on beta-cell-based therapeutic approaches in type 1 diabetes.
Azad A; Altunbas HA; Manguoglu AE
Expert Rev Endocrinol Metab; 2024 May; 19(3):217-227. PubMed ID: 38693782
[TBL] [Abstract][Full Text] [Related]
17. In Vivo Bioluminescence for the Detection of the Fate of Pancreatic Islet Organoids Post-transplantation.
Sun A; Kenyon E; Gudi M; Li W; Aguirre A; Wang P
Methods Mol Biol; 2023; 2592():195-206. PubMed ID: 36507995
[TBL] [Abstract][Full Text] [Related]
18. β-Cell replacement as a treatment for type 1 diabetes: an overview of possible cell sources and current axes of research.
Vieira A; Courtney M; Druelle N; Avolio F; Napolitano T; Hadzic B; Navarro-Sanz S; Ben-Othman N; Collombat P
Diabetes Obes Metab; 2016 Sep; 18 Suppl 1():137-43. PubMed ID: 27615143
[TBL] [Abstract][Full Text] [Related]
19. The Current Status of Allogenic Islet Cell Transplantation.
Czarnecka Z; Dadheech N; Razavy H; Pawlick R; Shapiro AMJ
Cells; 2023 Oct; 12(20):. PubMed ID: 37887267
[TBL] [Abstract][Full Text] [Related]
20. Beta-Cell Replacement: Pancreas and Islet Cell Transplantation.
Niclauss N; Meier R; Bédat B; Berishvili E; Berney T
Endocr Dev; 2016; 31():146-62. PubMed ID: 26824893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
